Anne ten Elzen - Grobbink

Researcher

Anne obtained her master’s degree in Biomedical Engineering at the University of Twente in 2021. During her time at the AST group in 2017, she contributed to the development of a retina-on-chip model for Age-related Macular Degeneration.

After working for 5 years in the start-up company 20Med Therapeutics, she returned to the AST group in 2025 as a researcher. Currently, she is working on the Pioneers in Healthcare project “A phantom coming to life”, where she focuses on developing an endothelial-lined phantom model for giant cell arteritis.

Her work involves developing a vessel-on-chip phantom for the detection of labeled microbubbles with Contrast-Enhanced ultrasound.